Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ADVANCE - Action in Diabetes and Vascular Disease: Preterax and Diamicron - MR Controlled Evaluation

Trial Profile

ADVANCE - Action in Diabetes and Vascular Disease: Preterax and Diamicron - MR Controlled Evaluation

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 28 Feb 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Gliclazide (Primary) ; Perindopril/indapamide (Primary) ; Antihyperglycaemics
  • Indications Cardiovascular disorders; Diabetic angiopathies; Diabetic complications; Diabetic nephropathies; Diabetic retinopathy; Hypertension; Myocardial infarction; Proteinuria; Stroke; Type 2 diabetes mellitus; Unstable angina pectoris
  • Focus Registrational; Therapeutic Use
  • Acronyms ADVANCE
  • Sponsors Servier
  • Most Recent Events

    • 17 Feb 2023 Results of post hoc analysis published in the Hypertension
    • 01 Aug 2022 Results published in the Clinical Journal of The American Society of Nephrology: CJASN
    • 01 Aug 2021 Results published in the Diabetes, Obesity and Metabolism
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top